PPT-Highlights for clinical

practice HIV International Congress of Drug Therapy in HIV Infection Glasgow UK 2326 October 2016 About the slide deck Goal How to reach the goal Structure of slide deck. --------------------------RECENT MAJOR CHANGES---------------------------- Boxed Warning 04/15 Indications and Usage (1.1) 04/15 Dosage and Administration (2.1, 2.2) 04/15 Warnings a Seville, 2013. Overview. Gabriele Cosmo, PH/SFT. Meeting’s Venue. Hosted in “Casa de la . Provincia. ” in the hearth of Seville. 7 October 2013. 2. Meeting’s Program. The 18. th. Collaboration Meeting. ELITE PRODUCT MANAGEMENT. PATTI GOETTEL. OCTOBER 2013. ENTERPRISE 3.10. FINANCIAL MANAGEMENT CONTENT. 3.10 enhancements determined in large measure by client votes on existing enhancement requests. Not all items that received votes are in 3.10, those with the highest number of votes that could be completed in the time frame . NDA 22-288/S-003 Reference ID: 3151309 NDA 22-288/S-003 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE BEPREVE (bepotastine besilate ophthalmic solution) 1.5% is a histamine H receptor antagoni Adults and Children 30 kg (66 lbs) or more: 0.3 to 0.5 mg (0.3 to 0.5 mL) intramuscularly or subcutaneously into anterolateral aspect of the thigh every 5 to 10 minutes as necessary (2.1) Children 30 National Highlights Report 2014 A Special Supplement to Education Week SciCOFish Steering Committee meeting. Noumea, March 2015. Coastal fisheries. Provide 50%–90. % of protein intake for coastal . communities. Very important for local incomes (provides around 50% of coastal households with 1. College of Health sciences. HEALTH CARE ADMINISTRATION . Employment opportunities in . HEALTH CARE ADMINISTRATION . Program details for . HEALTH CARE ADMINISTRATION . Highlights of . the HEALTH CARE ADMINISTRATION program. 7/20/2015. RedStone. Highlights . Drag Conveyor drive sprocket. Usually have to change out the sprocket & chain every 6 months. $15K expense. Customer believes they will get 2 years out of it now. . 5.1Hypersensitivity5.2Exogenous Ochronosis5.3Effects on Endocrine System5.4Cutaneous ReactionsADVERSE REACTIONSUSE IN SPECIFIC POPULATIONS8.1Pregnancy8.3NursingMothers8.4Pediatric Use8.5Geriatric Use1 Limitation of Use Should only be used for acute treatment periods up to two or three weeks (1)------------------------DOSAGE AND ADMINISTRATION------------------- DESCRIPTIONCLINCIAL PHARMACOLOGY12.1 Reference ID 3406989FULL PRESCRIBING INFORMATION INDICATIONS AND USAGE luliconazole Cream 1 is indicated for the topical treatment of interdigital tinea pedis tinea cruris and tinea corporis caused b Reference ID 4330857FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE TOBI is indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudom confidential. 2. Ph2 clinical program with IMB-101 in multiple indications with data read out in 2021/22. IMB-101 is an NCE with allowed claims and priority date in 2017. IMB-101 is well differentiated in both common and rare CV disease with large market potential and potential to be first in class in the USA.